Industry Verticals »

All Categories

Insights »

About TMR »

Oncology Nutrition Market

Schedule a Call

Oncology Nutrition Market

Oncology Nutrition Market (Distribution Channel: Inpatient Nutrition and Outpatient Nutrition; Nutrition: Enteral Nutrition and Parenteral Nutrition; Formula: Standard Formula, Elemental Formula, and Specialized Formula; and Cancer: Head and Neck Cancers, Colorectal Cancer, Hematology Cancer, Prostate Cancer, Breast Cancer, Gastrointestinal Cancer, Lung Cancer, Pancreatic Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Focus on Improving Oncology Care Worldwide to Boost Adoption of Oncology Therapies

Cancer is deemed as one of the most glaring causes of mortality and morbidity across the world. Due to advancements in technology and a significant amount of research, the oncology nutrition market is expected to witness considerable growth in the coming years. Oncology nutrition continues to remain an imperative area of focus for healthcare providers due to a consistent rise in the number of cases of malnutrition induced by tumors worldwide. Oncology nutrition plays an important role in improving bodily resources, tolerance of cancer treatments, and the overall quality of life. The decline in tolerance to cancer therapy is expected to provide fertile grounds of growth for companies operating in the current oncology nutrition market.

The significant rise in nutritional wasting and nutritional risk among cancer patients is a major factor that is anticipated to boost the growth of the oncology nutrition market during the forecast period. Participants in the current market landscape are currently investigating the potential benefits of adopting a multidisciplinary approach wherein targeted nutrition is likely to be imperative to enhance the quality of oncology care. Evolving guidelines, surge in observational studies, and growth in the number of clinical trials worldwide are some of the leading factors that are expected to propel the growth of the market for oncology nutrition in the coming years. At the back of these factors, the global oncology nutrition market is expected to reach ~US$ 1.4 Bn by the end of 2027.

oncology nutrition market infographic

To know the scope of our report Get a Sample on Oncology Nutrition Market

Progress in Nutritional Screening and Assessment Techniques to Drive Market

Nutritional screening and assessment techniques are integral to detect the identification of patients that are at a greater risk of malnourishment. Several studies have revealed that the incorporation of malnutrition screening in oncology care is expected to improve nutritional assessment and prevent malnutrition among patients. While nutritional risk continues to come under the radar, oncology nutrition is projected to gain a fair amount of momentum over the course of the assessment period. The demand for oncology nutrition is expected to further grow due to the notable surge in the adoption of nutritional assessment programs particularly during cancer cachexia and precachexia. Data collection techniques pertaining to the nutritional status of various patients have progressed at a rapid pace over the past decade. Due to these advancements, tailored oncology nutrition therapies have emerged as an ideal solution for cancer patients who are susceptible to malnutrition.

Get a glimpse of the in-depth analysis through our Report Brochure

Oncology nutrition therapies vary from patients to patients and at present, individualized oncology nutritional counseling has gained considerable pace. Oncology nutrition is increasingly being used to prevent nutritional deterioration among patients who are undergoing cancer care. Oral oncology nutrition is likely to gain considerable popularity as it has emerged as the preferred route of feeding. The demand for oncology nutrition to enhance the quality of life in cancer patients is on the rise– a major factor that is expected to provide a significant boost to the growth of the oncology nutrition market during the assessment period.

Stringent Guidelines Governing Oncology Nutrition to Influence Market Growth

One of the most glaring challenges that participants in the oncology nutrition market have had to deal with over several decades is the inadequate and unclear guidelines laid down by authoritative bodies due to which, oncology nutrition remained at the backseat. However, with additional research and growing awareness regarding the benefits of oncology nutrition, the structure within the healthcare systems is evolving. At present, within the oncology nutrition market, clinical nutrition specialists and oncologists are increasingly collaborating with each other in their efforts to improve oncology nutrition and oncology care. At present, recently laid down guidelines from different scientific bodies have focused on some key areas that are expected to improve the adoption of oncology nutrition in the coming years, including regular oncology nutritional therapy particularly for malnourished cancer patients, home artificial nutrition prescription, nutritional management, etc. The new guidelines would offer a boost to the adoption of oncology nutrition in the coming years, as the uptake of improved oncology nutrition therapies for cancer patients undergoing chemoradiotherapy is on the rise.

oncology nutrition market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global oncology nutrition market is expected to grow at a healthy CAGR of ~6% during the forecast period. The market growth can be primarily attributed to a range of factors, including rising in the prevalence of cancer patients, technological advancements, research & development activities, and growing awareness regarding oncology nutrition are some of the leading factors that will provide an impetus to the growth of the market for oncology nutrition during the forecast period. Focus on improving nutritional assessment among cancer patients due to the rise in the number of malnutrition cases will also play an important role in boosting the growth of the oncology nutrition market.  

Oncology Nutrition Market: Overview

  • According to Transparency Market Research’s latest report on the oncology nutrition market for the historical period 2017–2018 and forecast period 2019–2027, growing incidence of cancer, cancer supportive care products to meet the growing demand to treat cancer, entry of new players, and increase in access to health care are anticipated to drive the global oncology nutrition market
  • According to the report, the global oncology nutrition market was valued at US$ 836 Mn in 2018 and is projected to expand at a CAGR of ~6% from 2019 to 2027

Rise in Incidence of Cancer and Surge in Awareness about Usage and Benefits of Oncology Nutrition Supplements: A Key Driver

  • Cancer is the second leading cause of death globally, and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer. Approximately 70% of deaths from cancer occur in low- and middle-income countries.
  • Late-stage presentation and inaccessible diagnosis and treatment are common in low- and middle-income countries. In 2017, only 26% of low-income countries reported having pathology services generally available in the public sector.
  • Each cancer type requires unique treatment. Hence, increase in prevalence of cancer and the need for personalized medicine and nutrition are expected to increase the uptake of oncology nutrition diet. This is likely to provide significant opportunities for players in this market.

Focus on Geographic Expansion

  • Companies in the global oncology nutrition market are increasingly turning to in-licensing and collaboration agreements to launch new products in North America and Europe. Rise in demand to develop advanced or standard nutritional products for cancer, economic growth, and increase in awareness about oncology nutrition diet present significant opportunities for players operating in the global oncology nutrition market.
  • According to industry experts, high cost of oncology nutrition could hamper the market growth. This is particularly true for various underdeveloped and developing countries. Incidence of cancer is high in developing regions such as Asia, Africa, Latin America, and the Middle East. Hence, growth of oncology nutrition is expected to be faster in these regions. However, high cost of oncology specific supplements would be a deterrent for exploiting the full potential of these regions.

Stringent Regulatory Requirements to Hamper Market

  • Stringent regulatory requirements and long procedure for FDA approval have discouraged oncology nutrition manufacturers in the U.S. These are looking at regions such as Europe and Asia to launch newer products. Small private companies are doing much work in this area with some big pharmaceutical companies. These have put parenteral oncology nutrition for clinical trials.

Oncology Nutrition Market: Competition Landscape

  • This report profiles major players in the global oncology nutrition market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The oncology nutrition market is less fragmented, with the presence of a more international as well as regional players
  • Leading players operating in the global oncology nutrition market are 
    • Danone S.A.
    • Pfizer Inc.
    • B. Braun Melsungen AG
    • Fresenius Kabi AG
    • Grifols S.A.
    • Baxter International, Inc.
    • Nestlé S.A.
    • Abbott Laboratories
    • Sichuan Kelun Pharmaceutical Co., Ltd.
    • which account for more than 70% share of the market

Oncology Nutrition Market: Key Developments

  • Key players in the global oncology nutrition market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies of key players are likely to fuel the growth of the global oncology nutrition market. A few expansion strategies adopted by players operating in the oncology nutrition market are as follows:
    • In January 2020, Nestle purchased Allergan business to expand in medical nutrition
    • In September 2019, Smartfish AS collaborated with B. Braun to launch its medical nutrition product Remune. B. Braun launched Remune in close to 20 countries during 2019 and 2020, followed by several other markets in Europe, Asia, and South America
    • In 2018, Fresenius Kabi AG has launched mofKabiven extra Nitrogen, a three-chamber bag with a special protein-energy ratio, in Europe
    • In October 2018, the Baxter International Inc., in association with the American Society for Parenteral and Enteral Nutrition (ASPEN), launched the “SmartPN” tool aimed to reduce clinical malnutrition
  • The report on the global oncology nutrition market discussed individual strategies, followed by company profiles of manufacturers of oncology nutrition products. The ‘competition landscape’ section has been included in the oncology nutrition market report to provide readers with a dashboard view and a company market share analysis of key players operating in the global oncology nutrition market.

Oncology Nutrition Market - Segmentation

Distribution Channel

Inpatient Nutrition

Outpatient Nutrition

Nutrition

Enteral Nutrition

Parenteral Nutrition

Formula

Standard Formula

Elemental Formula

Specialized Formula

Cancer

Head and Neck Cancers

Colorectal Cancer

Hematology Cancer

Prostate Cancer

Breast Cancer

Gastrointestinal Cancer

Lung Cancer

Pancreatic Cancer

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of oncology nutrition market?

The global oncology nutrition market was worth US$ 836 Mn and is projected to reach a value of US$ 1.4 Bn by the end of 2027

What is the anticipated CAGR of the oncology nutrition market in forecast period?

Oncology nutrition market is anticipated to grow at a CAGR of 6% during the forecast period

Which region is expected to project the highest market share in oncology nutrition market?

North America accounted for a major share of the global oncology nutrition market

What are the key driving factors for the growth of oncology nutrition market?

Oncology nutrition market is driven by growing incidence of cancer, cancer supportive care products to meet the growing demand to treat cancer, entry of new players, and increase in access to health care are anticipated to drive the global market

Who are the key players in the global oncology nutrition market?

Key players in the global oncology nutrition market include Danone S.A., Pfizer Inc., B.Braun Melsungen AG, Fresenius Kabi AG, Grifols, S.A., Baxter International, Inc., Nestlé S.A., Abbott Laboratories, Sichuan Kelun Pharmaceutical Co., Ltd

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Oncology Nutrition Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Formula Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Oncology Nutrition Market Analysis and Forecast, 2017–2027

            4.4.1. Market Revenue Projections (US$ Mn)

        4.5. Porter’s Five Force Analysis

    5. Key Insights

        5.1. Health Care Industry Overview

        5.2. Cancer Incidence, by Key Country, in 2017

    6. Global Oncology Nutrition Market Analysis and Forecast, by Nutrition 

        6.1. Introduction & Definition

            6.1.1. Key Findings / Developments

        6.2. Global Oncology Nutrition Market Value Forecast, by Nutrition, 2017–2027

            6.2.1. Enteral Nutrition

            6.2.2. Parenteral Nutrition 

        6.3. Global Oncology Nutrition Market Attractiveness, by Nutrition 

    7. Global Oncology Nutrition Market Analysis and Forecast, by Formula 

        7.1. Introduction & Definition

            7.1.1. Key Findings / Developments

        7.2. Global Oncology Nutrition Market Value Forecast, by Formula, 2017–2027

            7.2.1. Standard Formula 

            7.2.2. Elemental Formula

            7.2.3. Specialized Formula 

        7.3. Global Oncology Nutrition Market Attractiveness, by Formula 

    8. Global Oncology Nutrition Market Analysis and Forecast, by Cancer 

        8.1. Introduction & Definition

            8.1.1. Key Findings / Developments

        8.2. Global Oncology Nutrition Market Value Forecast, by Cancer, 2017–2027

            8.2.1. Head and Neck Cancers

            8.2.2. Colorectal Cancer

            8.2.3. Hematology Cancer

            8.2.4. Prostate Cancer

            8.2.5. Breast Cancer

            8.2.6. Gastrointestinal Cancer

            8.2.7. Lung Cancer

            8.2.8. Pancreatic Cancer

            8.2.9. Other Cancers  

        8.3. Global Oncology Nutrition Market Attractiveness, by Cancer

    9. Global Oncology Nutrition Market Analysis and Forecast, by Distribution Channel 

        9.1. Introduction & Definition

            9.1.1. Key Findings / Developments

        9.2. Global Oncology Nutrition Market Value Forecast, by Distribution Channel, 2017–2027

            9.2.1. Inpatient Nutrition

            9.2.2. Outpatient Nutrition

        9.3. Global Oncology Nutrition Market Attractiveness, by Distribution Channel

    10. Global Oncology Nutrition Market Analysis and Forecast, by Region

        10.1. Key Findings

        10.2. Global Oncology Nutrition Market Value Forecast, by Region

            10.2.1. North America 

            10.2.2. Europe 

            10.2.3. Asia Pacific 

            10.2.4. Latin America 

            10.2.5. Middle East & Africa 

        10.3. North America Oncology Nutrition Market Attractiveness, by Region

    11. North America Oncology Nutrition Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

            11.2.1. Enteral Nutrition

            11.2.2. Parenteral Nutrition 

        11.3. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

            11.3.1. Standard Formula 

            11.3.2. Elemental Formula

            11.3.3. Specialized Formula  

        11.4. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

            11.4.1. Head and Neck Cancers

            11.4.2. Colorectal Cancer

            11.4.3. Hematology Cancer

            11.4.4. Prostate Cancer

            11.4.5. Breast Cancer

            11.4.6. Gastrointestinal Cancer

            11.4.7. Lung Cancer

            11.4.8. Pancreatic Cancer

            11.4.9. Other Cancers

        11.5. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            11.5.1. Inpatient Nutrition

            11.5.2. Outpatient Nutrition

        11.6. North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country, 2017–2027

            11.6.1. U.S.

            11.6.2. Canada

        11.7. North America Oncology Nutrition Market Attractiveness Analysis 

            11.7.1. By Nutrition 

            11.7.2. By Formula

            11.7.3. By Cancer

            11.7.4. By Distribution Channel

            11.7.5. By Country

    12. Europe Oncology Nutrition Market Analysis and Forecast

        12.1. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

            12.1.1. Enteral Nutrition

            12.1.2. Parenteral Nutrition 

        12.2. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

            12.2.1. Standard Formula 

            12.2.2. Elemental Formula

            12.2.3. Specialized Formula  

        12.3. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

            12.3.1. Head and Neck Cancers

            12.3.2. Colorectal Cancer

            12.3.3. Hematology Cancer

            12.3.4. Prostate Cancer

            12.3.5. Breast Cancer

            12.3.6. Gastrointestinal Cancer

            12.3.7. Lung Cancer

            12.3.8. Pancreatic Cancer

            12.3.9. Other Cancers

        12.4. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            12.4.1. Inpatient Nutrition

            12.4.2. Outpatient Nutrition

        12.5. Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            12.5.1. Germany

            12.5.2. U.K.

            12.5.3. France

            12.5.4. Spain

            12.5.5. Italy

            12.5.6. Rest of Europe 

        12.6. Europe Oncology Nutrition Market Attractiveness Analysis 

            12.6.1. By Nutrition 

            12.6.2. By Formula

            12.6.3. By Cancer

            12.6.4. By Distribution Channel

            12.6.5. By Country/Sub-region

    13. Asia Pacific Oncology Nutrition Market Analysis and Forecast

        13.1. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

            13.1.1. Enteral Nutrition

            13.1.2. Parenteral Nutrition 

        13.2. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

            13.2.1. Standard Formula 

            13.2.2. Elemental Formula

            13.2.3. Specialized Formula  

        13.3. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

            13.3.1. Head and Neck Cancers

            13.3.2. Colorectal Cancer

            13.3.3. Hematology Cancer

            13.3.4. Prostate Cancer

            13.3.5. Breast Cancer

            13.3.6. Gastrointestinal Cancer

            13.3.7. Lung Cancer

            13.3.8. Pancreatic Cancer

            13.3.9. Other Cancers

        13.4. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            13.4.1. Inpatient Nutrition

            13.4.2. Outpatient Nutrition

        13.5. Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            13.5.1. China

            13.5.2. Japan

            13.5.3. India

            13.5.4. Australia & New Zealand

            13.5.5. Rest of Asia Pacific 

        13.6. Asia Pacific Oncology Nutrition Market Attractiveness Analysis 

            13.6.1. By Nutrition 

            13.6.2. By Formula

            13.6.3. By Cancer

            13.6.4. By Distribution Channel

            13.6.5. By Country/Sub-region

    14. Latin America Oncology Nutrition Market Analysis and Forecast

        14.1. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

            14.1.1. Enteral Nutrition

            14.1.2. Parenteral Nutrition  

        14.2. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

            14.2.1. Standard Formula 

            14.2.2. Elemental Formula

            14.2.3. Specialized Formula  

        14.3. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

            14.3.1. Head and Neck Cancers

            14.3.2. Colorectal Cancer

            14.3.3. Hematology Cancer

            14.3.4. Prostate Cancer

            14.3.5. Breast Cancer

            14.3.6. Gastrointestinal Cancer

            14.3.7. Lung Cancer

            14.3.8. Pancreatic Cancer

            14.3.9. Other Cancers 

        14.4. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            14.4.1. Inpatient Nutrition

            14.4.2. Outpatient Nutrition

        14.5. Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            14.5.1. Brazil

            14.5.2. Mexico

            14.5.3. Rest of Latin America Latin America 

        14.6. Latin America Oncology Nutrition Market Attractiveness Analysis 

            14.6.1. By Nutrition 

            14.6.2. By Formula

            14.6.3. By Cancer

            14.6.4. By Distribution Channel

            14.6.5. By Country/Sub-region

    15. Middle East & Africa Oncology Nutrition Market Analysis and Forecast 

        15.1. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

            15.1.1. Enteral Nutrition

            15.1.2. Parenteral Nutrition  

        15.2. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

            15.2.1. Standard Formula 

            15.2.2. Elemental Formula

            15.2.3. Specialized Formula  

        15.3. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

            15.3.1. Head and Neck Cancers

            15.3.2. Colorectal Cancer

            15.3.3. Hematology Cancer

            15.3.4. Prostate Cancer

            15.3.5. Breast Cancer

            15.3.6. Gastrointestinal Cancer

            15.3.7. Lung Cancer

            15.3.8. Pancreatic Cancer

            15.3.9. Other Cancers

        15.4. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

            15.4.1. Inpatient Nutrition

            15.4.2. Outpatient Nutrition

        15.5. Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

            15.5.1. GCC Countries

            15.5.2. South Africa

            15.5.3. Rest of Middle East & Africa 

        15.6. Middle East & Africa Oncology Nutrition Market Attractiveness Analysis 

            15.6.1. By Nutrition 

            15.6.2. By Formula

            15.6.3. By Cancer

            15.6.4. By Distribution Channel

            15.6.5. By Country/Sub-region

    16. Competition Landscape

        16.1. Market Player - Competition Matrix (by Tier and Size of companies)

        16.2. Market Share / Position Analysis, by Company (2018)

        16.3. Company Profiles

            16.3.1. Fresenius SE & Co. KGaA

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Growth Strategies

                16.3.1.3. SWOT Analysis

            16.3.2. Pfizer, Inc.

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Growth Strategies

                16.3.2.3. SWOT Analysis

            16.3.3. Baxter International, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Growth Strategies

                16.3.3.3. SWOT Analysis

            16.3.4. B. Braun Melsungen AG

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Growth Strategies

                16.3.4.3. SWOT Analysis

            16.3.5. Abbott Laboratories

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Growth Strategies

                16.3.5.3. SWOT Analysis

            16.3.6. Grifols, S.A. 

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Growth Strategies

                16.3.6.3. SWOT Analysis 

            16.3.7. Allergan

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Growth Strategies

                16.3.7.3. SWOT Analysis

            16.3.8. Sichuan Kelun Pharmaceutical Co., Ltd.

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Growth Strategies

                16.3.8.3. SWOT Analysis

            16.3.9. Nestlé S.A.

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Growth Strategies

                16.3.9.3. SWOT Analysis

            16.3.10. Danone S.A.

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Growth Strategies

                16.3.10.3. SWOT Analysis

    List of Tables

    Table 01: Breast Cancer and Lung Cancer Incidence 

    Table 02: Pancreatic Cancer and Stomach Cancer Incidence 

    Table 03: Oral Cancer Incidence 

    Table 04: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 05: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 06: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 07: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    Table 08: Global Oncology Nutrition Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 09: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 10: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 11: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 12: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 13: North America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    Table 14: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 15: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 16: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 17: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 18: Europe Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    Table 19: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 20: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 21: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 22: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 23: Asia Pacific Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    Table 24: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 25: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 26: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 27: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 28: Latin America Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    Table 29: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 30: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Nutrition, 2017–2027

    Table 31: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Distribution Channel, 2017–2027

    Table 32: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Formula, 2017–2027

    Table 33: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

    List of Figures

    Figure 01: Global Oncology Nutrition Market Value (US$ Mn) Forecast, 2017–2027

    Figure 02: Global Oncology Nutrition Market Value Share (%), by Cancer, 2018

    Figure 03: Global Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018

    Figure 04: Global Oncology Nutrition Market Value Share (%), by Formula, 2018

    Figure 05: Global Oncology Nutrition Market Value Share (%), by Nutrition, 2018

    Figure 06: Global Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 07: Global Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 08: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Enteral nutrition,

    Figure 09: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral nutrition, 2017–2027

    Figure 10: Global Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 11: Global Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 12: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Inpatient Nutrition, 2017–2027

    Figure 13: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Outpatient Nutrition, 2017–2027

    Figure 14: Global Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 15: Global Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 16: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Standard Formula, 2017–2027

    Figure 17: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Elemental Formula, 2017–2027

    Figure 18: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialized Formula, 2017–2027

    Figure 19: Global Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 20: Global Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

    Figure 21: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Head and Neck Cancer, 2017–2027

    Figure 22: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Colorectal Cancer, 2017–2027

    Figure 23: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hematology Cancer, 2017–2027

    Figure 24: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Prostate Cancer, 2017–2027

    Figure 25: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer, 2017–2027

    Figure 26: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Cancer, 2017–2027

    Figure 27: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Lung Cancer, 2017–2027

    Figure 28: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pancreatic Cancer, 2017–2027

    Figure 29: Global Oncology Nutrition Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Cancers, 2017–2027

    Figure 30: Global Oncology Nutrition Market Value Share Analysis, by Region, 2018 and 2027

    Figure 31: Global Oncology Nutrition Market Attractiveness Analysis, by Region, 2019–2027

    Figure 32: North America Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 33: North America Oncology Nutrition Market Value Share Analysis, by Country, 2018 and 2027

    Figure 34: North America Oncology Nutrition Market Attractiveness Analysis, by Country, 2019–2027

    Figure 35: North America Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 36: North America Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 37: North America Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 38: North America Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 39: North America Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 40: North America Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 41: North America Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 42: North America Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

    Figure 43: Europe Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 44: Europe Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 45: Europe Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 46: Europe Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 47: Europe Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 48: Europe Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 49: Europe Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 50: Europe Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 51: Europe Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 52: Europe Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 53: Europe Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

    Figure 54: Asia Pacific Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 55: Asia Pacific Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 56: Asia Pacific Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 57: Asia Pacific Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 58: Asia Pacific Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 59: Asia Pacific Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 60: Asia Pacific Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 61: Asia Pacific Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 62: Asia Pacific Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 63: Asia Pacific Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 64: Asia Pacific Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

    Figure 65: Latin America Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 66: Latin America Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 67: Latin America Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 68: Latin America Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 69: Latin America Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 70: Latin America Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 71: Latin America Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 72: Latin America Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 73: Latin America Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 74: Latin America Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 75: Latin America Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

    Figure 76: Middle East & Africa Oncology Nutrition Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

    Figure 77: Middle East & Africa Oncology Nutrition Market Value Share Analysis, by Country/Sub-region, 2019–2027

    Figure 78: Middle East & Africa Oncology Nutrition Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 79: Middle East & Africa Oncology Nutrition Market Value Share (%), by Nutrition, 2018 and 2027

    Figure 80: Middle East & Africa Oncology Nutrition Market Attractiveness, by Nutrition, 2019–2027

    Figure 81: Middle East & Africa Oncology Nutrition Market Value Share (%), by Distribution Channel, 2018 and 2027

    Figure 82: Middle East & Africa Oncology Nutrition Market Attractiveness, by Distribution Channel, 2019–2027

    Figure 83: Middle East & Africa Oncology Nutrition Market Value Share (%), by Formula, 2018 and 2027

    Figure 84: Middle East & Africa Oncology Nutrition Market Attractiveness, by Formula, 2019–2027

    Figure 85: Middle East & Africa Oncology Nutrition Market Value Share (%), by Cancer, 2018 and 2027

    Figure 86: Middle East & Africa Oncology Nutrition Market Attractiveness, by Cancer, 2019–2027

Copyright © Transparency Market Research, Inc. All Rights reserved

We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic.

By clicking "Accept All", you consent to our use of cookies. Privacy Policy